Mike McDermott, chief global supply officer and executive vice-president at the pharmaceutical giant, said the company had a very strong development pipeline for new products, which needed flexible facilities.
“Our pipeline is incredibly strong, and we need facilities that can accept that pipeline and are nimble ...
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: